Technology that unlocks the abiliy to protect from the harms of stress and disease in the agriculture industry
Post-money valuation โ
$49.4M
As of Apr 2024 ยท from Zero Gravity Solutions Common Stock 1 ยท pre-money + amount raised, not a traded price
Total raised
$355,656
Across 1 round since 2024
Latest share price
$1.00
Zero Gravity Solutions Common Stock 1 offering price
Financials
FY2014โFY2022 ยท from SEC filings ยท hover any figure for its source
$11K
โ$2.9M
2014
$137K
โ$4.9M
2015
$218K
โ$7.0M
2016
$66K
โ$7.6M
2017
$45K
โ$5.4M
2018
$127K
โ$7.2M
2021
$31K
โ$4.7M
2022
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2014 audited
FY2015 audited
FY2016 audited
FY2017 audited
FY2018 audited
FY2021
FY2022
Income statement
Revenue
$11,218
$137,362
$218,166
$65,733
$45,263
$127,230
$31,300
Cost of goods sold
$2,609
$21,324
$51,567
$10,276
$38,442
$16,998
$3,040
Gross margin
77%
84%
76%
84%
15%
87%
90%
Net income
-$2,864,327
-$4,905,542
-$6,962,444
-$7,626,573
-$5,440,396
-$7,169,125
-$4,695,753
Taxes paid
$0
$0
$0
โ
โ
$0
$0
Balance sheet
Cash
$253,677
$2,851,000
$232,394
$13,862
$43,683
$105,746
$114,808
Accounts receivable
$1,325
$44,877
$121,747
$1,393
$342
$17,532
$12,642
Total assets
$588,229
$3,465,227
$1,075,163
$740,143
$552,152
$306,547
$295,715
Short-term debt
$104,647
$142,756
$195,355
$204,419
โ
$0
$0
Long-term debt
โ
โ
โ
โ
โ
$12,045,082
$14,012,152
Total liabilities
$104,647
$142,756
$195,355
$2,709,447
$5,648,305
$12,045,082
$14,012,152
Other
Headcount
โ
โ
โ
โ
โ
โ
10
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.